About Us

Jonathan Gillis, CPA, MSA

Jon is MapLight’s Chief Financial Officer. He is responsible for all of the Company’s finance functions and leads the management of general and administrative operations.  Jon brings over 15 years of combined public accounting and industry experience to the MapLight team. He joins from OvaScience, where he served as the Senior Vice President of Finance … Continued

Jon is MapLight’s Chief Financial Officer. He is responsible for all of the Company’s finance functions and leads the management of general and administrative operations.  Jon brings over 15 years of combined public accounting and industry experience to the MapLight team. He joins from OvaScience, where he served as the Senior Vice President of Finance … Continued

Anatol Kreitzer, Ph.D.

Anatol is MapLight’s Chief Discovery Officer and leads the Company’s platform development and target discovery efforts. Anatol brings over 20 years of experience in academic neuroscience research, focused on mechanisms of neuromodulation and the application of optogenetics, electrophysiology, and imaging to understand neural circuit function and dysfunction. Anatol is also a Professor at the Gladstone … Continued

Anatol is MapLight’s Chief Discovery Officer and leads the Company’s platform development and target discovery efforts. Anatol brings over 20 years of experience in academic neuroscience research, focused on mechanisms of neuromodulation and the application of optogenetics, electrophysiology, and imaging to understand neural circuit function and dysfunction. Anatol is also a Professor at the Gladstone … Continued

James Lillie, Ph.D.

Jim is the Maplight’s Chief Scientific Officer. He leads the Company’s preclinical research and development efforts.  Jim brings extensive cellular biology and biochemistry experience to MapLight with over 25 years of experience driving preclinical research and development across diverse therapeutic areas and indications. He joins MapLight from OvaScience where he served as the Chief Scientific … Continued

Jim is the Maplight’s Chief Scientific Officer. He leads the Company’s preclinical research and development efforts.  Jim brings extensive cellular biology and biochemistry experience to MapLight with over 25 years of experience driving preclinical research and development across diverse therapeutic areas and indications. He joins MapLight from OvaScience where he served as the Chief Scientific … Continued

Christopher Kroeger, M.D., MBA

Chris is the CEO and cofounder of MapLight Therapeutics.  Chris brings more than 20 years of experience leading, building and advising development-stage therapeutic and medical device companies, combined with the expertise of a physician and scientist. Chris previously served as the CEO of Cardioxyl Pharmaceuticals, leading a team that produced three investigational new drug candidates … Continued

Chris is the CEO and cofounder of MapLight Therapeutics.  Chris brings more than 20 years of experience leading, building and advising development-stage therapeutic and medical device companies, combined with the expertise of a physician and scientist. Chris previously served as the CEO of Cardioxyl Pharmaceuticals, leading a team that produced three investigational new drug candidates … Continued